Evolution in sites of recurrence over time in breast cancer patients treated with adjuvant endocrine therapy
Author:
Publisher
Elsevier BV
Subject
Radiology Nuclear Medicine and imaging,Oncology,General Medicine
Reference25 articles.
1. Breast-Cancer Recurrence after Stopping Endocrine Therapy
2. Annual hazard rates of recurrence for breast cancer during 24 years of follow-up: results from the International Breast Cancer Study Group Trials I to V;Colleoni;J Clin Oncol,2016
3. Evolution of sites of recurrence after early breast cancer over the last 20 years: implications for patient care and future research;Bouganim;Breast Cancer Res Treat,2013
4. Early Breast Cancer Trialists' Collaborative Group (EBCTCG), Davies C, Godwin J, Gray R, Clarke M, Cutter D, et al. Relevance of breast cancer hormone receptors and other factors to the efficacy of adjuvant tamoxifen: patient-level meta-analysis of randomised trials. Lancet 2011;378(9793):771–84.
5. Efficacy of extended adjuvant therapy with aromatase inhibitors in early breast cancer among common clinicopathologically-defined subgroups: a systematic review and meta-analysis;Goldvaser;Cancer Treat Rev,2017
Cited by 9 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Progression-free survival, disease-free survival and other composite end points in oncology: improved reporting is needed;Nature Reviews Clinical Oncology;2023-10-12
2. Exosomal circular RNA: a signature for lung cancer progression;Cancer Cell International;2022-12-01
3. A retrospective analysis of changes in distant and breast cancer related disease-free survival events in adjuvant breast cancer trials over time;Scientific Reports;2022-04-15
4. Cold Atmospheric Plasma Apoptotic and Oxidative Effects on MCF7 and HCC1806 Human Breast Cancer Cells;International Journal of Molecular Sciences;2022-02-01
5. The role of non-coding RNAs in ABC transporters regulation and their clinical implications of multidrug resistance in cancer;Expert Opinion on Drug Metabolism & Toxicology;2021-02-22
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3